Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 16 → 17·14:08, 21 Dec 2025
Difference between revision 16 and revision 17 of Qingdao Saber Technology Pharmaceutical. 2 lines changed; the page grew by 67 bytes.
| Revision 16 — 14:21, 4 Dec 2025 ArchiveBot (talk) bot: update parent category chain 12,131 bytes +1,609 | Revision 17 — 14:08, 21 Dec 2025 CheckSumChase (talk) correct the regional-warehouse list — six sites, not five 12,198 bytes +67 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://qingdaosabertechnology.com/ Go to the QST catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 78 | The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |